x |
| T12-NEWS reports that the PDL BioPharma's Revenue for its 12 month ended September 30, 2009 Increased by 10.89% |
|
Stock Quote: (NasdaqNM:PDLI) |
| 11/16/2009 |
|
| 6.22 |
 -0.01 |
-0.16% |
1,272,757 |
|
| T12-NEWS reports that the PDL BioPharma's Revenue for its 12 month ended September 30, 2009 Increased by 10.89% |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, NY, November 16, 2009,T12-NEWS reports that Revenue for PDL BioPharma (NASDAQ:PDLI) for its trailing twelve months (TTM) ended September 30, 2009 was $328,590,000, a 10.89% increase over the ... read full story |
|
| Website Address: |
www.pdl.com |
| Industry: |
Vaccine, Antibodies, Immunities
|
|
|
|
